Literature DB >> 29233819

Characterization of Interactions Among CYP1A2, CYP2B4, and NADPH-cytochrome P450 Reductase: Identification of Specific Protein Complexes.

J Patrick Connick1, James R Reed1, Wayne L Backes2.   

Abstract

Cytochromes P450s (P450s) catalyze oxygenation reactions via interactions with their redox partners. However, other proteins, particularly other P450s, also have been shown to form complexes that modulate P450 function. Previous studies showed that CYP1A2 and CYP2B4 form a complex when reconstituted into phospholipid vesicles; however, details of the interactions among the P450s and NADPH-cytochrome P450 reductase (POR) have not been fully characterized. The goal of this study was to examine P450 complex formation in living cells, using bioluminescence resonance energy transfer (BRET). Various pairs of P450 and POR constructs were tagged with either green fluorescent protein or Renilla luciferase, and transfected into human embryonic kidney 293T cells. Complexes were demonstrated by measuring energy transfer between the tags, and disruption of the complex was verified by cotransfection with unlabeled P450-system proteins. CYP1A2 and CYP2B4 formed a stable complex that could not be disrupted by cotransfection of untagged POR. Interactions of both P450s with POR were detected, with untagged CYP1A2 disrupting the POR-CYP2B4 interaction. In contrast, untagged CYP2B4 did not affect the POR-CYP1A2 interaction. These data are consistent with POR preferentially binding to the CYP1A2 moiety of CYP1A2-CYP2B4. BRET-detectable homomeric CYP1A2-CYP1A2 also was detected, and was disrupted by cotransfection of either POR or CYP2B4. Both CYP1A2 and CYP2B4 activities were affected by their coexpression in a manner consistent with formation of the high-affinity POR-CYP1A2-CYP2B4 complex. These findings demonstrate that CYP1A2 and CYP2B4 form a heteromeric POR-CYP1A2-CYP2B4 complex in living cells that has altered catalytic activities relative to the homomeric enzymes.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29233819      PMCID: PMC5797933          DOI: 10.1124/dmd.117.078642

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  40 in total

1.  Association of cytochromes P450 1A2 and 2B4: are the interactions between different P450 species involved in the control of the monooxygenase activity and coupling?

Authors:  D R Davydov; N A Petushkova; E V Bobrovnikova; T V Knyushko; P Dansette
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

2.  Studies on the association of cytochrome P-450 and NADPH-cytochrome c reductase during catalysis in a reconstituted hydroxylating system.

Authors:  G T Miwa; S B West; M T Huang; A Y Lu
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

3.  Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction.

Authors:  J A Peterson; R E Ebel; D H O'Keeffe; T Matsubara; R W Estabrook
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

4.  Cytochrome P450 system proteins reside in different regions of the endoplasmic reticulum.

Authors:  Ji Won Park; James R Reed; Lauren M Brignac-Huber; Wayne L Backes
Journal:  Biochem J       Date:  2014-12-01       Impact factor: 3.857

5.  CYP2C8 exists as a dimer in natural membranes.

Authors:  Gang Hu; Eric F Johnson; Byron Kemper
Journal:  Drug Metab Dispos       Date:  2010-08-10       Impact factor: 3.922

6.  Studies on the rate-determining factor in testosterone hydroxylation by rat liver microsomal cytochrome P-450: evidence against cytochrome P-450 isozyme:isozyme interactions.

Authors:  D R Dutton; S K McMillen; A J Sonderfan; P E Thomas; A Parkinson
Journal:  Arch Biochem Biophys       Date:  1987-06       Impact factor: 4.013

7.  Relationship between CYP1A2 localization and lipid microdomain formation as a function of lipid composition.

Authors:  Lauren M Brignac-Huber; James R Reed; Marilyn K Eyer; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2013-08-20       Impact factor: 3.922

8.  Interactions among cytochromes P-450 in the endoplasmic reticulum. Detection of chemically cross-linked complexes with monoclonal antibodies.

Authors:  K Alston; R C Robinson; S S Park; H V Gelboin; F K Friedman
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

Review 9.  The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.

Authors:  Tom Lynch; Amy Price
Journal:  Am Fam Physician       Date:  2007-08-01       Impact factor: 3.292

Review 10.  Physical Studies of P450-P450 Interactions: Predicting Quaternary Structures of P450 Complexes in Membranes from Their X-ray Crystal Structures.

Authors:  James R Reed; Wayne L Backes
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

View more
  3 in total

Review 1.  Assembling the P450 puzzle: on the sources of nonadditivity in drug metabolism.

Authors:  Dmitri R Davydov; Bhagwat Prasad
Journal:  Trends Pharmacol Sci       Date:  2021-09-30       Impact factor: 14.819

Review 2.  The Biosynthesis of Enzymatically Oxidized Lipids.

Authors:  Ali A Hajeyah; William J Griffiths; Yuqin Wang; Andrew J Finch; Valerie B O'Donnell
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-19       Impact factor: 5.555

3.  Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells.

Authors:  Tamara Heintze; Kathrin Klein; Ute Hofmann; Ulrich M Zanger
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.